Shareholders to Vote on Major Equity Plan Expansion and Evergreen Provision
PSTV is trading near its 52-week low of $0.16 (0.9% below the low) on elevated volume (2.6× avg).
Summary
Plus Therapeutics proposes a significant expansion of its equity incentive plan, including an additional 18.5 million shares and a 5% annual evergreen provision, which could lead to substantial dilution for shareholders amidst Nasdaq compliance efforts.
Key Events · Corporate Governance and Compliance · PSTV
-
Annual Shareholder Meeting Scheduled
The company will hold its Annual Meeting of Stockholders on May 14, 2026, where key proposals will be voted upon.
-
Significant Equity Plan Expansion Proposed
Shareholders will vote on the Sixth Amendment and Restatement of the 2020 Stock Incentive Plan, which proposes to increase the shares available for issuance by 18.5 million. This represents approximately 10.78% of the 171,550,698 shares outstanding as of March 18, 2026.
-
New Evergreen Provision for Annual Share Increase
The amended plan includes an evergreen provision for an automatic annual increase of 5% of outstanding shares for the plan's share reserve over the next nine years, starting January 1, 2027.
-
Context of Nasdaq Compliance and Reverse Split
This proposal comes as the company faces a Nasdaq delisting risk and has concurrently announced a reverse stock split to increase its per-share trading price, highlighting the critical need for capital and employee retention strategies.
Analysis · PSTV · Industrial Applications And Services
Plus Therapeutics, a company facing a Nasdaq delisting risk and having recently announced a reverse stock split to address it, is seeking shareholder approval for a significant expansion of its 2020 Stock Incentive Plan. The proposed amendment would increase the shares available for issuance by 18.5 million, representing approximately 10.78% of current outstanding shares. Additionally, an evergreen provision would be introduced, allowing for an automatic annual increase of 5% of outstanding shares for the next nine years. While essential for employee retention and motivation, this substantial potential dilution is a critical consideration for existing shareholders, especially given the company's current financial challenges and its stock trading near 52-week lows. The shareholder meeting is scheduled for May 14, 2026.
At the time of this filing, PSTV was trading at $0.16 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $27.9M. The 52-week trading range was $0.16 to $1.22. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.